Condition

Solid Tumor Malignancy clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Solid Tumor Malignancy clinical trials that are recruiting, at sites in 2 countries (most in China (2), United States (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Solid Tumor Malignancy clinical trials

StudyPhaseWhereStatusRegistered
SIBP-A18 injection for advanced malignant solid tumors Phase 1 Beijing, Beijing Municipality Recruiting May 22, 2025
68Ga/177Lu-NRT6020 imaging and targeted therapy for FAP-positive advanced solid tumors Phase 1 Shanghai and 1 other locations Recruiting Apr 4, 2025
Collecting long-term safety and survival data from patients treated with Century Therapeutics cellular therapy — Gilbert, Arizona and 6 other locations Recruiting Mar 14, 2023

All recruiting trials (3)

Related topics

Hematological Malignancy

Quick answers

How many Solid Tumor Malignancy clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in China (2 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.